Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
EV/Core EBITDA

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 31.8134.08--0.060.10

What is the latest EV/Core EBITDA ratio of CONCORD BIOTECH ?

The latest EV/Core EBITDA ratio of CONCORD BIOTECH is 31.81 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202531.81
Mar202434.08
Mar2023-
Mar2022-0.06
Mar20210.10

How is EV/Core EBITDA of CONCORD BIOTECH Trending?

Years EV/Core EBITDA % Change
Mar2025 31.81
-6.66
Mar2024 34.08
0
Mar2023 0
100.00
Mar2022 -0.06
Negative
Mar2021 0.1 -

Other Financial Ratios of CONCORD BIOTECH


Compare EV/Core EBITDA ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹12,534.7 Cr -0.6% -10.5% -32.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,999.0 Cr 3.6% 7% 15.3% Stock Analytics
DIVIS LABORATORIES ₹169,139.0 Cr 1.1% 5.8% 14.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,791.0 Cr 1.9% 12.3% 49.2% Stock Analytics
DR REDDYS LABORATORIES ₹109,664.0 Cr 1.8% 5.9% 14.8% Stock Analytics
CIPLA ₹107,685.0 Cr 1.6% 0.2% -5.4% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-0.6%

-10.5%

-32.5%

SENSEX

-2.5%

-6.1%

7%


You may also like the below Video Courses